Peptide Therapy for Psychiatry: Targeted Biological Signaling, Carefully Sequenced
The question we start with: which biological system is interfering with this person's mental-health recovery, cognitive performance, sleep, energy, or ability to participate in treatment?
Individualized care begins with the biological obstacle, not with a preassembled stack.
Sourced Right: 503a Compounding, Fully Compliant
Every peptide used at Peak Body and Mind is sourced from FDA-regulated 503A compounding pharmacies, the licensed pharmacies that compound patient-specific prescriptions under direct FDA and state board oversight. We do not source from research-chemical vendors, gray-market suppliers, or any channel outside that regulated system.
We do not offer any injectable peptide currently placed on the FDA's Category 2 bulk drug substances list. Category 2 is a specific FDA sourcing designation, not a DEA schedule: it means 503A pharmacies are not currently permitted to compound that substance, pending FDA's further review. When a peptide sits in that category, it stays off our list, full stop, regardless of our own clinical view of it.
This is an evolving regulatory picture, and we track it closely. FDA's own Pharmacy Compounding Advisory Committee has already voted to recommend restoring several Category 2 peptides to compoundable status, and that process is ongoing. We are watching it and will update our available options as the landscape develops, without ever getting ahead of it.
None of this limits what we can offer you today. The number of well-characterized, legitimately compoundable peptides available to us is large, and it covers the biological systems most relevant to psychiatric care: sleep and circadian signaling, stress-circuit regulation, neurotrophic and neuroplasticity support, mitochondrial energy production, and more. We also have effective options outside the injectable category entirely: oral and intranasal peptide delivery are both well-established routes for many of the categories below. Compliance and clinical range are not in tension here.
Peptide Therapy Is Not A Stack. It Is A Clinical Question.
Peptides are short biological signals. Different therapies communicate with different systems, and those systems are not interchangeable. In psychiatry, sleep disruption, persistent stress activation, low energy, cognitive fatigue, metabolic change, and inflammatory burden can all affect stability and participation in care, but not in the same way for everyone. Our role is to identify the most relevant biological question, select only the categories that fit, and sequence them within the broader plan. Sometimes the right answer is not peptide therapy at all.
Signaling
Categories, Not Product Lists
We organize peptide therapy by the biological system involved, not by brand or product. The category helps define the clinical question; it does not automatically define the treatment.
Biology
That Can Matter to Mental Health
When a relevant biological pattern is identified in depression, anxiety, trauma-related symptoms, sleep-wake disruption, cognitive symptoms, fatigue, or metabolic change, selected signaling therapies may become one part of a broader plan.
Not a Generic Stack
Or a Guaranteed Shortcut
We do not sell prebuilt stacks, promise a universal response, or present one category as the answer for everyone. Evidence varies by therapy and indication, and good care includes that uncertainty.
The Biological Categories We Consider
The categories below are an educational map of how we think. They are not a menu, a diagnosis, or a promise that every category belongs in every plan.
- Sleep & Circadian Signaling
Sleep is part of the treatment environment for the brain. When sleep is fragmented, poorly timed, or affected by nighttime hyperarousal, this category supports more restorative sleep and overnight recovery.
- Stress-Circuit & Calming Signaling
Persistent stress activation interferes with sleep, focus, and emotional regulation. Selected calming-signaling therapies are considered when anxiety, hyperarousal, or trauma-related stress physiology is clinically relevant. The goal is to reduce biological interference, not simply to sedate.
- Neurotrophic & Neuroplasticity Signaling
Learning, memory, and cognitive flexibility depend on complex signaling. In selected patients, this category is considered for depression, trauma-related symptoms, cognitive complaints, or difficulty adapting after prolonged stress.
- Mitochondrial & Cellular-Energy Signaling
Fatigue, slowed thinking, and poor recovery become barriers to treatment. When the clinical picture or labs point toward a cellular-energy question, this category supports energy production and recovery capacity.
- Gut-Brain, Barrier & Inflammatory Signaling
For some patients, inflammatory or gut-brain factors affect sleep, energy, cognition, and mood. When history or testing identifies a meaningful context, selected therapies are considered.
Oral Bioregulator Signaling
A distinct category of short signaling peptides taken orally rather than by injection, drawn from a research lineage (originating in Soviet-era gerontology research) built around organ-specific tissue regulation and epigenetic, DNA-methylation-related aging biology. These are considered for patients where a longer-term, lower-intensity signaling approach fits the clinical picture, including sleep and circadian regulation, stress-axis support, and general tissue-aging biology, often alongside or as a lead-in to the injectable categories above rather than a substitute for them. As an oral category, it sits outside the FDA's Category 2 injectable bulk-substance framework entirely, and adds further clinically relevant range to what we can offer.
Where Peptide Categories May Fit With Ketamine
Ketamine is one component. It is not the whole architecture. When ketamine is considered, we place it inside a larger plan rather than treating it as an isolated event, and selected peptide categories are considered before, around, after, or separately from it. Timing is a clinical decision, made individually, not an automatic recipe.
Before
When sleep, stress physiology, energy, or metabolic health is interfering with treatment participation.
Around
Coordinated with a broader psychiatric intervention when the overall plan supports it.
After
Follow-up focused on sleep, recovery, energy, stress regulation, or cognition once an intervention has occurred.
Separate from ketamine
Many patients are evaluated for peptide therapy without ketamine. These categories do not depend on it.
How Peptide Therapy Follows The Peak Method
A sophisticated plan is not defined by how many therapies it contains. It is defined by whether each therapy has a reason to be there.
Understand the Person Before Selecting a Category
We begin with an in-depth psychiatric and biological assessment: symptoms, treatment history, medications, sleep, stress, cognition, energy, medical context, goals, and relevant labs. When clinically useful, the baseline includes Brain Gauge and WAVi EEG to understand cognitive processing and brain electrical activity over time.
Choose the Relevant Signaling Category
If peptide therapy is appropriate, we select the category that best fits the clinical picture and decide whether it belongs before, around, after, or separately from other care. Before treatment, we discuss goals, evidence, safety, medication context, monitoring, and the limits of what the therapy can reasonably be expected to do.
Review What Is Happening, and Adjust With Purpose
Follow-up is where clinical reasoning continues. We look at lived experience alongside symptoms, sleep, energy, cognition, stress regulation, labs, and the broader plan. Optimization does not mean adding more. It means making the next decision more informed.
F.A.Q.
FDA-regulated 503A compounding pharmacies, the same licensed, inspected pharmacy channel used for individualized prescriptions across medicine. We do not use research-chemical vendors or unregulated suppliers.
No. We do not offer any injectable peptide currently on the FDA's Category 2 bulk drug substances list, the substances 503A pharmacies are not currently permitted to compound while FDA review is ongoing. FDA's own advisory committee has already voted to recommend restoring several of these, and we are watching that process closely. In the meantime, that still leaves a large, clinically capable range of legitimately compoundable peptides across every category relevant to psychiatric care, plus effective oral and intranasal options outside the injectable category entirely.
No. We don't begin with a preassembled combination. We start with the biological obstacle and consider whether a peptide category is relevant to it, choosing the smallest plan that has a clear reason to exist.
It is considered as one part of a broader psychiatric plan when a relevant biological pattern, such as sleep, stress physiology, energy, or inflammatory signaling, is interfering with recovery. It is not a stand-alone treatment.
Selected categories are considered before, around, after, or separately from ketamine. Timing is an individualized clinical decision.
No. Many patients are evaluated for peptide therapy without ketamine. These categories do not depend on it.
Poor sleep, persistent stress activation, cognitive fatigue, low energy, metabolic disruption, difficulty recovering, or a psychiatric plan that hasn't addressed the whole picture.
No. Evidence varies substantially by therapy and indication. We are direct about what is known, what is plausible, and what still requires careful observation.
Through individualized screening and a full review of your medications, medical history, symptoms, and goals, with monitoring and follow-up over time.
No. It is used within psychiatric care, not in place of it, and is not a substitute for medication, therapy, or other indicated treatment.
A clinical discovery call is a focused conversation about the problem you're trying to solve and whether peptide therapy is an appropriate part of the answer. You don't need to arrive with a peptide name or a stack.
The right starting point is the right question
You don't need to arrive with a peptide name, a stack, or a treatment recipe. Bring the problem you're trying to solve: poor sleep, persistent stress, cognitive fatigue, low energy, metabolic disruption, difficulty recovering, or a psychiatric plan that hasn't addressed the whole picture. We'll help determine which questions deserve a closer look, and whether peptide therapy is an appropriate part of the answer.
This page is for general education and describes categories of care, not specific products or guaranteed outcomes. It is not a diagnosis or a substitute for individualized medical advice. Your clinician determines what is appropriate for your case following a complete evaluation. If you are in crisis, call or text 988, call 911, or go to the nearest emergency department.
